Status:
COMPLETED
Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids
Lead Sponsor:
Kochi University
Conditions:
Liver Cancer
Eligibility:
All Genders
16-90 years
Phase:
NA
Brief Summary
The long-term outcomes of branched-chain amino acid (BCAA) administration in patients undergoing hepatic resection remain unclear. The aim of this study is to assess the impact of oral supplementation...
Detailed Description
This study might demonstrate a tendency of the improvement in the cumulative tumor recurrence rate after hepatectomy for liver neoplasm in the Livact group compared to that in the Control Group. The i...
Eligibility Criteria
Inclusion
- These patients were scheduled for elective liver resection to treat hepatocellular carcinoma or adenocarcinoma of the liver.
Exclusion
- a body-weight loss greater than 10% during the 6 months prior to surgery,
- the presence of distant metastases, or
- serious impairment of organ function due to respiratory, renal, or heart disease.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT01434524
Start Date
April 1 2007
End Date
June 1 2011
Last Update
September 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kochi Medical School
Nankoku, Kochi, Japan, 783-8505